# Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

> **NCT03251027** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 100 (actual)

## Conditions studied

- Glioblastoma
- WHO Grade II Glioma
- WHO Grade III Glioma

## Interventions

- **RADIATION:** Intensity-Modulated Radiation Therapy
- **OTHER:** Quality-of-Life

## Key facts

- **NCT ID:** NCT03251027
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-17
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251027, "Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03251027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*